Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Botta

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|December 1, 1987
[Effect of treatment with captopril on the quality of life in hypertensive patients. Multicenter study in ambulatory patients]S Liberatore, G F Botta, L Uccioli
Digestive Diseases and Sciences|May 5, 2000
Oral or intravenous lidocaine administration to perform megx test?E Giannini, F Botta, P Romagnoli, et al.
Italian Journal of Gastroenterology and Hepatology|March 17, 1999
Wilson's disease with concomitant beta thalassaemia and factor V deficiencyE Giannini, A Fasoli, F Botta, et al.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|April 1, 1989
[Assessment of tolerability and antihypertensive efficacy of aceplus mite (captopril (CPT) 50 mg + hydrochlorothiazide (HCTZ) 15 mg): a double-blind study vs. HCTZ in diabetic hypertensive patients. A report on three treatments]A Santucci, R De Cesaris, R Buoninconti, et al.
La Radiologia Medica|July 12, 2008
Biological effective dose evaluation in gynaecological brachytherapy: LDR and HDR treatments, dependence on radiobiological parameters, and treatment optimisationC Bianchi, F Botta, L Conte, et al.
Therapeutic Drug Monitoring|August 15, 2000
The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosisF Botta, E Giannini, A Fasoli, et al.
Minerva Medica|October 1, 1989
[Captopril and hydrochlorothiazide combined in the treatment of mild-to-moderate hypertension. Evaluation of sugar and lipid metabolism in a long-term study]E Malacco, M Magenta, E Noia, et al.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|April 1, 1989
[Evaluation of the efficacy and tolerability of a fixed dose combination of captopril (CPT) 50 mg and hydrochlorothiazide (HCTZ) 15 mg in the elderly]R Antonicelli, S Raffaelli, A Bossini, et al.
Histology and Histopathology|April 5, 2012
Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like featuresV Martin, F Botta, E Zanellato, et al.
Therapeutic Drug Monitoring|August 15, 2000
Histologic determinants of monoethylglycinexylidide formation in patients with chronic hepatitis CR Testa, E Giannini, P Ceppa, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|December 1, 1987
[Effect of treatment with captopril on the quality of life in hypertensive patients. Multicenter study in ambulatory patients]S Liberatore, G F Botta, L Uccioli
Digestive Diseases and Sciences|May 5, 2000
Oral or intravenous lidocaine administration to perform megx test?E Giannini, F Botta, P Romagnoli, et al.
Italian Journal of Gastroenterology and Hepatology|March 17, 1999
Wilson's disease with concomitant beta thalassaemia and factor V deficiencyE Giannini, A Fasoli, F Botta, et al.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|April 1, 1989
[Assessment of tolerability and antihypertensive efficacy of aceplus mite (captopril (CPT) 50 mg + hydrochlorothiazide (HCTZ) 15 mg): a double-blind study vs. HCTZ in diabetic hypertensive patients. A report on three treatments]A Santucci, R De Cesaris, R Buoninconti, et al.
La Radiologia Medica|July 12, 2008
Biological effective dose evaluation in gynaecological brachytherapy: LDR and HDR treatments, dependence on radiobiological parameters, and treatment optimisationC Bianchi, F Botta, L Conte, et al.
Therapeutic Drug Monitoring|August 15, 2000
The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosisF Botta, E Giannini, A Fasoli, et al.
Minerva Medica|October 1, 1989
[Captopril and hydrochlorothiazide combined in the treatment of mild-to-moderate hypertension. Evaluation of sugar and lipid metabolism in a long-term study]E Malacco, M Magenta, E Noia, et al.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|April 1, 1989
[Evaluation of the efficacy and tolerability of a fixed dose combination of captopril (CPT) 50 mg and hydrochlorothiazide (HCTZ) 15 mg in the elderly]R Antonicelli, S Raffaelli, A Bossini, et al.
Histology and Histopathology|April 5, 2012
Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like featuresV Martin, F Botta, E Zanellato, et al.
Therapeutic Drug Monitoring|August 15, 2000
Histologic determinants of monoethylglycinexylidide formation in patients with chronic hepatitis CR Testa, E Giannini, P Ceppa, et al.
Pageof 5